Dexamethasone 0.5mg/5ml solution in Mucolox™ ( DrugBank: Dexamethasone )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
35	Pemphigus	1
162	Pemphigoid	1

35. Pemphigus

---

Clinical trials : 99 /  Drugs : 124 - (DrugBank : 36) / Drug target genes : 23 - Drug target pathways : 169

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04540133 (ClinicalTrials.gov)	December 26, 2020	28/8/2020	Dexamethasone Solution and Dexamethasone in Mucolox™	Dexamethasone Solution and Dexamethasone in Mucolox™ for the Treatment of Oral Inflammatory Ulcerative Diseases	Oral Lichen Planus;Mucous Membrane Pemphigoid;Pemphigus Vulgaris;Chronic Graft-versus-host-disease	Drug: dexamethasone 0.5mg/5ml solution;Drug: dexamethasone 0.5mg/5ml solution in Mucolox™	University of California, San Francisco	NULL	Completed	18 Years	N/A	All	29	Phase 2	United States

162. Pemphigoid

---

Clinical trials : 90 /  Drugs : 122 - (DrugBank : 47) / Drug target genes : 34 - Drug target pathways : 144

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04540133 (ClinicalTrials.gov)	December 26, 2020	28/8/2020	Dexamethasone Solution and Dexamethasone in Mucolox™	Dexamethasone Solution and Dexamethasone in Mucolox™ for the Treatment of Oral Inflammatory Ulcerative Diseases	Oral Lichen Planus;Mucous Membrane Pemphigoid;Pemphigus Vulgaris;Chronic Graft-versus-host-disease	Drug: dexamethasone 0.5mg/5ml solution;Drug: dexamethasone 0.5mg/5ml solution in Mucolox™	University of California, San Francisco	NULL	Completed	18 Years	N/A	All	29	Phase 2	United States